Syndax Announces Participation in Cowen 2nd Annual Virtual Oncology Innovation Summit
Syndax Pharmaceuticals announced its participation in the Cowen 2nd Annual Virtual Oncology Innovation Summit on May 20, 2021, at 12:00 p.m. ET. The management team will present details about their innovative cancer therapy pipeline, including SNDX-5613, axatilimab, and entinostat. A live webcast of the presentation can be accessed through the Company's website, with a replay available for a limited time thereafter.
- Participation in a significant industry event enhances visibility.
- Presentation of a promising pipeline of cancer therapies.
- None.
WALTHAM, Mass., May 13, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in the Cowen 2nd Annual Virtual Oncology Innovation Summit on Thursday, May 20, 2021 at 12:00 p.m. ET.
A live webcast of the presentation can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn.
Syndax Contacts
Investor Contact
Melissa Forst
Argot Partners
melissa@argotpartners.com
Tel 212.600.1902
Media Contact
Ted Held
ted.held@gcihealth.com
Tel 212.798.9842
SNDX-G
View original content:http://www.prnewswire.com/news-releases/syndax-announces-participation-in-cowen-2nd-annual-virtual-oncology-innovation-summit-301290613.html
SOURCE Syndax Pharmaceuticals, Inc.
FAQ
When is Syndax participating in the Cowen 2nd Annual Virtual Oncology Innovation Summit?
What are the key therapies that Syndax Pharmaceuticals is developing?
How can I watch Syndax's presentation at the oncology summit?
What time does Syndax's presentation at the summit start?
